Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats

被引:4
作者
Deniz, H
Ögütmen, B
Çakalagaoglu, F
Tuglular, S
Özener, Ç
Akoglu, E
机构
[1] Marmara Univ, Sch Med, Dept Internal Med, Istanbul, Turkey
[2] Marmara Univ, Sch Med, Div Nephrol, Istanbul, Turkey
[3] Marmara Univ, Sch Med, Dept Pathol, Istanbul, Turkey
关键词
D O I
10.1016/j.transproceed.2005.12.056
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of our study was to investigate the influence of angiotensin-converting enzyme (ACE) inhibition and angiotensin II receptor blockage on the renal function by light microscopic and immunohistochemical findings in a rat model of tacrolimus nephrotoxicity. thirty-two male Wistar rats were divided into four groups of eight: G1 = control group; G2-G3, G4 = Tacrolimus (Tac) 1 mg/kg/d intraperitoneally (ip); G3 (Tac + Q) = ip Tac and peroral quinapril 10 mg/kg; and G4 (Tac + V) = Tac and valsartan 40 mg/d. Serum blood urea nitrogen (BUN), creatinine, and creatinine clearance were measured before and at the end of the study period. Renal tissues were assessed for light microscopic findings of tacrolimus toxicity. Transforming growth factor-beta, VEGF, PDGF, BMP-7, and interleukin-6 (IL-6) expression were semiquantitatively scored after immunohistochemical staining. At the end of the study period serum BUN and creatinine levels were increased in all groups, but creatinine clearance was not significantly changed between the groups. Afferent arteriolopathy was significantly less pronounced in G3 versus G2 and G4. Interstial fibrosis was significantly less pronounced in G3 and G4 versus G2. TGF-beta, PDGF, and IL-6 expression were significantly increased in G2, G3, and G4 compared to G1, and in G2 compared to G3 and G4. BMP-7 expression was significantly decreased in G2, G3, and G4 compared to G1, whereas the differences between G2, G3, and G4 failed to reach statistical significance. In conclusion, the results of our study suggested that renin angiotensin inhibition down-regulates fibrogenic cytokine expression in rats displaying tacrolimus nephrotoxicity.
引用
收藏
页码:483 / 486
页数:4
相关论文
共 25 条
[1]   Interactions of transforming growth factor-β and angiotensin II in renal fibrosis [J].
Border, WA ;
Noble, NA .
HYPERTENSION, 1998, 31 (01) :181-188
[2]   TGF-β and fibrosis [J].
Branton, MH ;
Kopp, JB .
MICROBES AND INFECTION, 1999, 1 (15) :1349-1365
[3]   Vasoactive hormones and renal sclerosis - Discussion [J].
Egido, J .
KIDNEY INTERNATIONAL, 1996, 49 (02) :578-597
[4]   PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis [J].
Gilbert, RE ;
Kelly, DJ ;
McKay, T ;
Chadban, S ;
Hill, PA ;
Cooper, ME ;
Atkins, RC ;
Nikolic-Paterson, DJ .
KIDNEY INTERNATIONAL, 2001, 59 (04) :1324-1332
[5]   Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-κB transcription factors [J].
Han, YQ ;
Runge, MS ;
Brasier, AR .
CIRCULATION RESEARCH, 1999, 84 (06) :695-703
[6]   Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells [J].
Imanishi, T ;
Hano, T ;
Nishio, I .
HYPERTENSION RESEARCH, 2004, 27 (02) :101-108
[7]   Effect of anti-transforming growth factor-β antibodies in cyclosporine-induced renal dysfunction [J].
Islam, M ;
Burke, JF ;
McGowan, TA ;
Zhu, YQ ;
Dunn, SR ;
McCue, P ;
Kanalas, J ;
Sharma, K .
KIDNEY INTERNATIONAL, 2001, 59 (02) :498-506
[8]   Vascular endothelin, TGF-beta, and PDGF expression in FK506 nephrotoxicity of rats [J].
Jeong, HJ ;
Kim, YS ;
Hong, IC .
TRANSPLANTATION PROCEEDINGS, 1998, 30 (07) :3596-3597
[9]   Tacrolimus versus ciclosporin immunosuppression: long-term outcome in renal transplantation [J].
Jurewicz, WA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 :7-11
[10]   ANGIOTENSIN-II STIMULATES EXTRACELLULAR-MATRIX PROTEIN-SYNTHESIS THROUGH INDUCTION OF TRANSFORMING GROWTH-FACTOR-BETA EXPRESSION IN RAT GLOMERULAR MESANGIAL CELLS [J].
KAGAMI, S ;
BORDER, WA ;
MILLER, DE ;
NOBLE, NA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2431-2437